Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New Developments in Peptide Receptor Radionuclide Therapy

20 Dec 2018

Abstract excerpt

Peptide receptor radionuclide therapy (PRRT) is an established treatment for nonoperable or metastatic neuroendocrine neoplasms that highly and frequently express somatostatin receptors. More generally, PRRT is an attractive therapy option for delivering cytotoxic radiation to tumor cells through specific binding of a radiolabeled peptide to a molecular target. The development of imaging companions gave rise to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Research Studies
Share to Neuroendocrine Tumor Research Advances
Share to Radiopharmaceutical Chemistry and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30573642
DOI: 10.2967/jnumed.118.213496

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New Developments in Peptide Receptor Radionuclide TherapyPMID 30573642Read ↗

Radiopeptide Imaging and Therapy in the United StatesSemantic proximity Read ↗

Molecular imaging probes derived from natural peptidesSemantic proximity Read ↗

Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Advanced Neuroendocrine Tumours (NETs) in a Limited Resource EnvironmentSemantic proximity Read ↗

Somatostatin Receptor Based Imaging and Radionuclide TherapySemantic proximity Read ↗

Nuclear medicine and molecular imaging advances in the 21st centurySemantic proximity Read ↗

Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work BetterSemantic proximity Read ↗

DNA-PKcs inhibitors sensitize neuroendocrine tumor cells to peptide receptor radionuclide therapy in vitro and in vivoSemantic proximity Read ↗

Cancer Targeting Radiopeptidomimetics in Molecular Nuclear MedicineSemantic proximity Read ↗

A pan-cancer analysis of the clinical and genetic portraits of somatostatin receptor expressing-tumor as a potential target of peptide receptor imaging and therapySemantic proximity Read ↗

Secretin receptor as a target in gastrointestinal cancer: expression analysis and ligand developmentSemantic proximity Read ↗

Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cellsSemantic proximity Read ↗

Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant TumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.